Underutilization of lipid-lowering therapy in coronary artery disease
- PMID: 10999994
- DOI: 10.1001/archinte.160.17.2683
Underutilization of lipid-lowering therapy in coronary artery disease
Comment on
-
Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) Investigators.Arch Intern Med. 2000 Feb 14;160(3):343-7. doi: 10.1001/archinte.160.3.343. Arch Intern Med. 2000. PMID: 10668836 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
